Cargando…
Hybrid LNP Prime Dendritic Cells for Nucleotide Delivery
The efficient activation of professional antigen‐presenting cells—such as dendritic cells (DC)—in tumors and lymph nodes is critical for the design of next‐generation cancer vaccines and may be able to provide anti‐tumor effects by itself through immune stimulation. The challenge is to stimulate the...
Autores principales: | Das, Riddha, Halabi, Elias A., Fredrich, Ina R., Oh, Juhyun, Peterson, Hannah M., Ge, Xinying, Scott, Ella, Kohler, Rainer H., Garris, Christopher S., Weissleder, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667837/ https://www.ncbi.nlm.nih.gov/pubmed/37814359 http://dx.doi.org/10.1002/advs.202303576 |
Ejemplares similares
-
Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages
por: Arlauckas, Sean P., et al.
Publicado: (2018) -
In Vivo Click Chemistry Enables Multiplexed Intravital Microscopy
por: Ko, Jina, et al.
Publicado: (2022) -
TNIK Inhibition Has Dual Synergistic Effects on Tumor and Associated Immune Cells
por: Kim, Jaehee, et al.
Publicado: (2022) -
LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix™ in VZV-primed mice
por: Luan, Ning, et al.
Publicado: (2022) -
The effects of PEGylation on LNP based mRNA delivery to the eye
por: Ryals, Renee C., et al.
Publicado: (2020)